THE USE OF NICOTINE, ANALOGUES THEREOF, PRECURSORS THEREOF OR DERIVATIVES THEREOF IN THE TREATMENT OF VARIOUS PATHOLOGICAL PROCESSES CAPABLE OF IMPROVEMENT WITH a-MSH ADMINISTERED IN PROPHYLACTIC OR THERAPEUTIC FORM
Disclosed is the use of nicotine in the preparation of a medicament for the treatment of: post traumatic bleeding (hyplema) proliferative retinopathies in eye fibroblasts initial stages of retrolental fibroplasias proliferative diabetic retinopathies post traumatic proliferative retinopathies proliferative retinopathies caused by hypoxia infectious conditions or infectious syndromes to one or more of a liver, kidney, and lung degenerative osteoarthrosis eclampsyia Parkinson or Alzheimer diseases rejection of transplanted tissues ischemia to a kidney, lung or intestines deterioration to a liver or blood vessels caused by lipopolysaccharides bacterial infections of a liver or liver cirrhosis depression obesity pain relief in late term pregnancy, in the absence diabetes hypertension or neuropathy antecedents such that in use the medicament Induces or stimulates release of alpha-MSH.
